Abstract:Hypoxic microenvironment and pancreatic stellate cells (PSCs) play important roles in pancreatic cancer progression. PSCs secrete a number of soluble factors, such as interleukin (IL)‑6, to facilitate cancer metastasis. Our previous study revealed that curcumin inhibited the invasive ability of pancreatic cancer cells by modulating epithelial‑to‑mesenchymal transition (EMT)‑related factors. However, whether curcumin could suppress tumor‑stromal crosstalk in pancreatic cancer and the underlying mechanisms have yet to be fully elucidated. The aim of the present study was to evaluate whether curcumin could affect pancreatic cancer cell invasion and EMT by interfering with tumor‑stromal interaction under hypoxic conditions. The PSCs were treated with curcumin under hypoxic conditions. The activation of PSCs was detected by testing the expression of α‑smooth muscle actin by western blotting and immunofluorescence analysis. The wound healing assay was used to evaluate the migratory potential of PSCs. The secretion and expression of IL‑6 by PSCs was detected by ELISA and reverse transcription‑quantitative PCR (RT‑qPCR) analysis. BxPC‑3 and Panc‑1 cells were treated with PSC‑conditioned media (PSC‑CM), IL‑6, IL‑6‑neutralizing antibody or curcumin under conditions of normoxia or hypoxia. Transwell invasion assay was used to examine the invasive potential of pancreatic cancer cells. The activation of phosphorylated (p‑) extracellular signal‑regulated kinase (ERK) and p‑nuclear factor (NF)‑κB were measured by western blot analysis. The expression of EMT‑related genes at the mRNA and protein levels was detected by RT‑qPCR and western blot analysis, respectively. The results of the present study demonstrated that curcumin inhibited the activation and migration of PSCs under hypoxic conditions. Curcumin also suppressed the secretion and expression of IL‑6 in PSCs. In addition, curcumin and IL‑6‑neutralizing antibody treatment suppressed PSC‑CM‑modulated pancreatic cancer invasion, EMT and the changes in the expression of E‑cadherin, vimentin and matrix metallopeptidase‑9. Furthermore, the increase in the levels of p‑ERK and p‑NF‑κB induced by PSC‑CM could be counterbalanced by both curcumin and IL‑6‑neutralizing antibody treatment under hypoxic conditions. Taken together, these data indicate that curcumin plays an important role in suppressing tumor‑stromal crosstalk and pancreatic cancer metastasis by inhibiting the IL‑6/ERK/NF‑κB axis. Blocking the IL‑6/ERK/NF‑κB axis by curcumin may be a promising therapeutic strategy for the treatment of pancreatic cancer.

Curcumin inhibits the invasion and migration of pancreatic cancer cells by upregulating TFPI-2 to regulate ERK- and JNK-mediated epithelial–mesenchymal transition

Curcumin Inhibits Pancreatic Cancer Cell Invasion and EMT by Interfering with Tumor‑stromal Crosstalk under Hypoxic Conditions Via the IL‑6/ERK/NF‑κB Axis.

Curcumin Suppresses Epithelial-to-mesenchymal Transition and Metastasis of Pancreatic Cancer Cells by Inhibiting Cancer-Associated Fibroblasts.

Curcumin Inhibits H2O2-induced Invasion and Migration of Human Pancreatic Cancer Via Suppression of the ERK/NF-κB Pathway.

Curcumin Inhibits Superoxide Dismutase-Induced Epithelial-to-mesenchymal Transition Via the PI3K/Akt/NF-κB Pathway in Pancreatic Cancer Cells.

Curcumin inhibits the migration and invasion of mouse hepatoma Hca-F cells through down-regulating caveolin-1 expression and epidermal growth factor receptor signaling.

Curcumin Attenuates Hyperglycemia-Driven EGF-induced Invasive and Migratory Abilities of Pancreatic Cancer Via Suppression of the ERK and AKT Pathways

Curcumin inhibits tumor epithelial-mesenchymal transition by downregulating the Wnt signaling pathway and upregulating NKD2 expression in colon cancer cells

Curcumin Inhibits Hypoxia-Induced Epithelial-Mesenchymal Transition in Pancreatic Cancer Cells Via Suppression of the Hedgehog Signaling Pathway

Curcumin inhibits pancreatic cancer cell proliferation by regulating Beclin1 expression and inhibiting the hypoxia-inducible factor-1α-mediated glycolytic pathway

Retracted: Notch‐1 Down‐regulation by Curcumin is Associated with the Inhibition of Cell Growth and the Induction of Apoptosis in Pancreatic Cancer Cells

Curcumin induces down-regulation of EZH2 expression through the MAPK pathway in MDA-MB-435 human breast cancer cells.

Study of the Mechanism by Which Curcumin Cooperates with Sestrin2 to Inhibit the Growth of Pancreatic Cancer

Curcumin Inhibits Epithelial-Mesenchymal Transition in Colorectal Cancer Cells by Regulating Mir-206/Snai2 Pathway

Curcumin Suppresses Migration and Invasion of Human Endometrial Carcinoma Cells

Effects of Curcumin on Invasion and Metastasis of Human Pancreatic Cancer Cells PANC-1

Curcumin Suppresses Colon Cancer Cell Invasion Via AMPK-induced Inhibition of NF–κB, Upa Activator and MMP9

Curcumin Inhibits Constitutive STAT3 Phosphorylation in Human Pancreatic Cancer Cell lines and Downregulation of Survivin/BIRC5 Gene Expression

Curcumin Inhibits the Migration and Invasion of Human A549 Lung Cancer Cells Through the Inhibition of Matrix Metalloproteinase-2 and -9 and Vascular Endothelial Growth Factor (VEGF).

Curcumin Affects Proprotein Convertase Activity: Elucidation of the Molecular and Subcellular Mechanism

Curcumin Inhibits the Invasion of Lung Cancer Cells by Modulating the PKCα/Nox-2/ROS/ATF-2/MMP-9 Signaling Pathway.